Future studies are needed to fully validate the European Scleroderma Study Group activity index and the Combined Response Index for Systemic Sclerosis. PubMed, Clin Exp Rheumatol, 07/06/2016. (Also see Prognosis and Mortality)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.